Eduardo
López Pelaez
Novartis (Sweden)
Täby, SueciaPublicacións en colaboración con investigadores/as de Novartis (Sweden) (2)
2004
-
Failure to deplete anti-Galα1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galα1-3Gal oligosaccharides
Xenotransplantation, Vol. 11, Núm. 5, pp. 408-415
2001
-
Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-Galactosyl IgG antibodies
Xenotransplantation, Vol. 8, Núm. 1, pp. 15-23